FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves Teva's supplemental application for the generic fixed-dose combination emtricitabine and tenofovir disoproxil fumarate for the treatment of HIV-1 i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• Emtricitabine and Tenofovir Disoproxil Fumarate (emtricitabine and tenofovir disoproxil fumarate)

Snippet

SUPPL AP for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)